University of Minnesota
240 Williamson Hall
231 Pillsbury Drive S.E.
About University of Minnesota
About the U of M
The University of Minnesota is one of the most comprehensive public universities in the United States and ranks among the most prestigious. It is both the state land-grant university, with a strong tradition of education and public service, and the state's primary research university, with faculty of national and international reputation.
The University of Minnesota's cutting-edge research and creation of new knowledge significantly contributes to world understanding and learning. As the state's primary research institution, the University receives 98 percent of all federally sponsored research grants awarded to higher education institutions in Minnesota.
The College of Biological Sciences at the University of Minnesota is one of few colleges nationwide devoted to biological sciences. CBS explores a world of opportunities, from molecules to ecosystems, to improve human health, develop renewable resources, enhance agriculture, and restore the environment.
Last Updated: 02-10-2006
231 articles with University of Minnesota
Calyxt Launches U.S. Field Trials With University of Minnesota For Powdery Mildew-Resistant Spring Wheat Variety
Groundbreaking: University of Minnesota Research Shows People Can Control A Robotic Arm With Only Their Minds
Abbott, Hennepin County Medical Center And University of Minnesota Collaborate To Launch The Nation's Largest, Single-Center Prospective Study On Concussion And Traumatic Brain Injury
University of Minnesota Study Confirms Bracelet-Like Device For Acid Reflux Safe, Effective 5 Years After Implantation
University of Minnesota Grants Calyx Therapeutics Inc. An Exclusive License To Its Homologous Recombination Technology In Plants
Fate Therapeutics And Regents Of The University of Minnesota Enter Into Research Collaboration For Translation Of Natural Killer Cell Cancer Immunotherapies
In Hearings, University of Minnesota Admits Problems in Solvay Pharmaceuticals, Inc.’s Schizophrenia Drug
REGENXBIO Licenses Key Technologies From University of Pennsylvania And University of Minnesota For The Development Of Treatments For MPS I And MPS II
Federal Grant Awarded To The University of Minnesota To Study The Efficacy Of Remote Monitoring In Alzheimer's Care